Condition: Colorectal Cancer · Epithelial Ovarian Cancer · Gastric Cancer (GC) · Sponsor: Blue Earth Diagnostics
This is a multi-centre, open-label, single-arm, Phase 2 study designed to evaluate the diagnostic performance of \[68Ga\]BED003 in detecting colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
This description comes directly from the study's public registry record.
Jamie MacKay · 44 (0)1865 507300 · contact@blueearthdx.com
Jason Kane · 44 (0)1865 507300 · contact@blueearthdx.com
Always discuss trial participation with your own doctor first.
| Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII | Bergamo, Lombardy, Italy | Recruiting |
| Fondazione IRCCS San Gerardo dei Tintori | Monza, Lombardy, Italy | Not Yet Recruiting |
| Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore | Roma, Roma, Italy | Not Yet Recruiting |
| IRCCS Ospedale San Raffaele | Milan, Segrate, Italy | Recruiting |
| University Medical Center Groningen | Groningen, Netherlands | Recruiting |
| Stichting Radboud Universitair Medisch Centrum | Nijmegen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07702292